AGTR1 and hypertensive disorder: Relatedly, PHM for 4 weeks in SHRSPs initiated during the plateau phase of their hypertension development (aged 21 weeks) did not significantly alter the blood pressure (Extended Data Fig. 10a−c), although it did decrease AT1R expression in RVLM astrocytes, but not neurons (Extended Data Fig. 10d−f).